Page last updated: 2024-09-03

ro 32-0432 and sb 415286

ro 32-0432 has been researched along with sb 415286 in 1 studies

Compound Research Comparison

Studies
(ro 32-0432)
Trials
(ro 32-0432)
Recent Studies (post-2010)
(ro 32-0432)
Studies
(sb 415286)
Trials
(sb 415286)
Recent Studies (post-2010) (sb 415286)
56013116052

Protein Interaction Comparison

ProteinTaxonomyro 32-0432 (IC50)sb 415286 (IC50)
Serine/threonine-protein kinase/endoribonuclease IRE1Homo sapiens (human)1.3
G2/mitotic-specific cyclin-B2Homo sapiens (human)0.9
Cyclin-dependent kinase 1Homo sapiens (human)0.9
G2/mitotic-specific cyclin-B1Homo sapiens (human)0.9
Cyclin-A2Homo sapiens (human)0.38
Cyclin-dependent kinase 2Homo sapiens (human)0.38
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.104
Glycogen synthase kinase-3 betaHomo sapiens (human)0.1108
Cyclin-A1Homo sapiens (human)0.38
G2/mitotic-specific cyclin-B3Homo sapiens (human)0.9
large T antigenBetapolyomavirus macacae55.43

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avnur, Z; Dunten, P; Gong, L; Heather Hogg, J; Hirschfeld, D; Peltz, G; Tan, YC1

Other Studies

1 other study(ies) available for ro 32-0432 and sb 415286

ArticleYear
Discovery of potent and bioavailable GSK-3beta inhibitors.
    Bioorganic & medicinal chemistry letters, 2010, Mar-01, Volume: 20, Issue:5

    Topics: Administration, Oral; Animals; Binding Sites; Crystallography, X-Ray; Disease Models, Animal; Drug Discovery; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Maleimides; Mice; Protein Kinase C; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship

2010